share_log

Benchmark Reiterates Buy on Quipt Home Medical, Maintains $10 Price Target

Benzinga Real-time News ·  Feb 13, 2023 07:43

Benchmark analyst Bill Sutherland reiterates Quipt Home Medical (NASDAQ:QIPT) with a Buy and maintains $10 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment